LONDON, July 29 (Reuters) - A further slide in sales of lung drug Advair and lower profit margins following a business overhaul hit GlaxoSmithKline in the second quarter, although core earnings per share fell by a less-than-expected 9 percent. The drugmaker recently sold its marketed cancer
Read moreLAGOS, July 28 (Reuters) - GSK's Nigerian unit said on Tuesday its first-half pretax profit fell to 424.8 million naira ($2.14 million), down 66.05 percent from a year ago. Revenue also fell to 15.44 billion naira in the period to end-June from 15.66 billion naira last year, the unit of Br
Read more(ShareCast News) - There is an inevitable dividend question hanging over the two big oil companies, the Times' Tempus column said. Royal Dutch Shell and BP, both reporting this week, offer among the best yields in the market, in excess of 6%. If the payments are maintained, they remain attractive i
Read more